Totient Bio

Fantastic news for Milner-affiliated company @TotientBio! "Together, AbSci & Totient are much more than the sum of our parts, with clear opportunities for synergy of our platforms and technologies," said Deniz Kural, PhD, co-founder and CEO of Totient. prnewswire.com/news-releases/…

Today, we are celebrating the acquisition of our portfolio company @TotientBio by @abscibio. Another great success started @labcentral with @MissionBioCap as investor. Great work by @denizkural & team - Congratulations! prnewswire.com/news-releases/…

Welcome, Prof. Simon Tavaré, PhD, FRS FMedSci, @royalsociety, @acmedsci, @Cancer_dynamics, Bharath Ramsundar, PhD @rbhar90 @deepforestsci, Chris Powell, PhD, FRCPath, FRSB, FBTS, @BritToxSoc @Cambridge_Uni, & Prof. Duncan Jodrell, DM, MSc, FRCP(Edin.), @RCPEdin, @ECMC_UK @CR_UK

We are pleased to announce the formation of our new Scientific Advisory Board. prnewswire.com/news-releases/…

We're on @joinClubhouse! Tune in on Saturday to hear our cofounders @denizkural and @SietstraJames talk ML and human-derived antibodies with @rbhar90 on @dnatieclub.

Totient's manuscript describing the first large scale study of antigens recognized by fully human intratumoral antibodies is now available on bioRxiv. biorxiv.org/content/10.110…

Learn more about our exciting new partnership with @TotientBio! ow.ly/uxys50BSi0w

We are pleased to announce that Totient has partnered @IntegralMoleclr to screen our antibodies against one of the world's largest (6,000!) collections of native human membrane proteins. prnewswire.com/news-releases/…

Thanks @JFruehauf @labcentral @MissionBioCap! Your early support of Totient's discovery platform and vision was a key enabler of today's milestone.

Thank you @MNakada! So grateful for your support over the years!

Check out our feature in @endpts! We are thrilled to publicly share our novel approach to identifying COVID-19 neutralizing antibodies from infection sites in the lung. Thanks to @Ginkgo @jrkelly @ECratsenburg @AnnaMarieWagner @AveraHealth endpts.com/exclusive-gink…

Totient Partners with @Ginkgo Bioworks to Apply Unique Discovery Platform to COVID-19 Antibody Efforts prnewswire.com/news-releases/…

Time for @Ginkgo's mammalian foundry to shine ? “We’re hoping we become a household name" -Narendra Maheshri, head of mammalian biology "We're sampling antibodies directly involved in tissues under #COVID19 attack" -@denizkural, @TotientBio $BLI #synbio endpts.com/exclusive-gink…

We are excited to emerge from stealth and share what our team of 19 immunologists, cancer biologists, medical doctors, computational chemists, and machine learning and bioinformatics engineers have been working on! prnewswire.com/news-releases/…